Generali Investments Towarzystwo Funduszy Inwestycyjnych Regeneron Pharmaceuticals, Inc. Transaction History
Generali Investments Towarzystwo Funduszy Inwestycyjnych
- $172 Billion
- Q4 2024
A detailed history of Generali Investments Towarzystwo Funduszy Inwestycyjnych transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Generali Investments Towarzystwo Funduszy Inwestycyjnych holds 1,401 shares of REGN stock, worth $976,567. This represents 0.58% of its overall portfolio holdings.
Number of Shares
1,401
Previous 1,097
27.71%
Holding current value
$976,567
Previous $1.15 Billion
13.46%
% of portfolio
0.58%
Previous 0.73%
Shares
10 transactions
Others Institutions Holding REGN
# of Institutions
1,496Shares Held
82.9MCall Options Held
1.22MPut Options Held
1.5M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.5 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.89 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.22 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.42 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...